[11C]Yohimbine PET Study of alpha2-AR

Clinical trial NCT03520543 · COMPLETED

Trial details

NCT number: NCT03520543
Sponsor: Hospices Civils de Lyon
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Controls

Start date: 2018-05-21
Primary completion: 2018-07-21
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.